Industry Research by Koncept Analytics
Global Antifungal Market: Industry Analysis & Outlook ----------------------------------------(2016-2020) November 2016
Global Antifungal Market: Industry Analysis & Outlook (20162020)
1
Executive Summary Fungal infection is most common in those with weakened immune system or those who have foreign material, including medical devices in their body like an artificial joint or heart valve. Fungal infections are categorized under opportunistic and primary fungal infection. Opportunistic fungal infection targets weak immune patients and can be very aggressive, spreading quickly to other organs and often leading to death. While primary fungal infection can occur in people with a normal immune system, sometimes with serious consequence. There are several types of antifungal medicines. They come in as creams, sprays, solutions, tablets designed to go into the vagina (pessaries), shampoos, medicines to take by mouth, and injections. Most work by damaging the cell wall of the fungus, which causes the fungal cell to die. The US is the largest market of anti-fungal drugs. It has the presence of the leading companies who specialize in anti-fungal drugs. The key factors driving growth of the anti-fungal market include rise in incidences of fungal infections in immuno-compromised patients, increase in number of cancer patients, rise in incidences of fungal infections in people suffering from AIDS, increase in spending on medicines, rise in sale of prescription drugs and many more. However, market growth is hindered by the factors such as harsh side effects of drugs, drug resistance, high cost of anti-fungal, and lack of new anti-fungal therapies. The major trends featuring the market includes increase in development of new drugs, flourishing public-private partnership in pharmaceutical industry, and growing awareness. The report offers an in-depth analysis of the “Global Anti-Fungal Market� with special focus on invasive antifungal segment. It covers the regional and global aspects of the market. The top notch players in the market exhibit a very close competition. The report profiles JNJ, Novartis, Pfizer, and Merck & Co.
Global Antifungal Market: Industry Analysis & Outlook (20162020)
2
The global anti-fungal market is largely driven by rise in population with weak immune system due to cancer and other immunodeficiency syndrome…. Global Anti-Fungal Market by Value (2011-2015)
Global Invasive Anti-Fungal Market Forecast by Value (20162020)
•
The global anti-fungal market value reached US$.. billion in 2015, increasing from US$.. billion in the previous fiscal year. The market grew at a CAGR of ..% for the period spanning 2011-2015.
•
The global invasive reach US$.. billion billion in 2016. The CAGR of .. % for the
•
The global invasive anti-fungal market’s majority of the share was held by XX drugs i.e. .. % in 2015.
anti-fungal market is expected to by 2020, increasing from US$.. market is estimated to grow at a period spanning 2016-2020.
Global Invasive Anti-Fungal Market by Drug Class (2015)
Global Antifungal Market: Industry Analysis & Outlook (20162020)
3
With rise in incidences of fungal infections, the need for better and cost effective drugs will rise. This would create more opportunities…. Global Invasive Anti-Fungal Market by Target Patients (2015)
North America Anti-Fungal Market Forecast by Value (2016-2020)
•
..% of the invasive fungal infections, are majorly caused by Candida fungi, happen to patients XX , followed by leukemia with ..%.
•
The North American anti-fungal market value is expected to reach US$.. billion by 2020, increasing from US$.. billion in 2016, growing at a CAGR of ..% from 2016-2020.
•
European anti-fungal market value is estimated to reach US$.. billion by 2020, increasing from US$.. billion in 2016. The market is expected to grow at a CAGR of ..% for the period spanning 2016-2020.
Europe Anti-Fungal Market Forecast by Value (20162020)
Global Antifungal Market: Industry Analysis & Outlook (20162020)
4
Contact Us:
Disclaimer
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com
Global Antifungal Market: Industry Analysis & Outlook (20162020)
5